Expression of α2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas

Tanaka,Kyoko; Mikami,Mikio; Aoki,Daisuke; Kiguchi,Kazushige; Ishiwata,Isamu; Iwamori,Masao

doi:10.3892/ol.2010.171

Expression of α2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas

Authors:
- Kyoko Tanaka
- Mikio Mikami
- Daisuke Aoki
- Kazushige Kiguchi
- Isamu Ishiwata
- Masao Iwamori
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo 160-8582, Japan, Department of Obstetrics and Gynecology, School of Medicine, Tokai University, Kanagawa 259-1193, Department of Obstetrics and Gynecology, St Marianna University School of Medicine, Kanagawa 216-8511, Japan, Ishiwata Gynecologic Hospital, Ibaraki 310-0041, Japan, Department of Biochemistry, Faculty of Science and Technology, Kinki University, Osaka 577-8502, Japan
Published online on: September 9, 2010 https://doi.org/10.3892/ol.2010.171
Pages: 1061-1066

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

To identify glycolipid antigens associated with histologically defined types of ovarian carcinomas, we determined the amounts of α2,6-sialyl and Lewis-active glycolipids, the specific activities of the α2,3- and α2,6-sialyltransferases, and the gene expression of sugar transferases in mucinous and serous cystadenocarcinoma, clear cell adenocarcinoma and endometrioid carcinoma tissues and cell lines derived from them. α2,6-sialyl glycolipid IV6NeuAcα-nLc4Cer detected with a newly developed monoclonal antibody, Y916, was present in 5/7 serous cystadenocarcinoma cases in relatively higher amounts than those in the other carcinoma tissues. On the other hand, the amounts of Lewis-active glycolipids in serous cystadenocarcinoma tissues were lower than those in the other carcinoma tissues. No correlation was observed between the structures of Lewis glycolipids and the histological classification. The gene expression of α2,3- and α2,6-sialyltransferases and α1,3/4-fucosyltransferase for the synthesis of Lewis-active glycolipids was not positively correlated with the amounts of the respective glycolipids, probably due to the epigenetic regulation of transferases in the overall metabolic pathways for lacto-series glycolipids. However, the amounts of GM3 and GD3 with short carbohydrate chains correlated with the relative intensities of GM3 and GD3 synthase gene expression, respectively. Among ovarian carcinoma-derived cell lines, the serous cystadenocarcinoma-derived ones exhibited a lower frequency of Lewis-active glycolipid expression than the other carcinoma-derived ones, which was similar to that in the respective tissues. Thus, malignancy-related Lewis-active glycolipids were shown to be regulated in different modes in ovarian serous cystadenocarcinomas and the other carcinomas.

View Figures

View References

1	Roseman S: Reflections on glycobiology. J Biol Chem. 276:41527–41542. 2001. View Article : Google Scholar : PubMed/NCBI
2	Koprowski H, Herlyn M, Steplewski Z and Sears HF: Specific antigen in serum of patients with colon carcinoma. Science. 212:53–55. 1981. View Article : Google Scholar : PubMed/NCBI
3	Canney PA, Wilkinson PM, James RD and Moore M: CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125. Br J Cancer. 52:131–133. 1985. View Article : Google Scholar : PubMed/NCBI
4	Sgroi D, Varki A, Braesch-Andersen S and Stamenkovic I: CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J Biol Chem. 268:7011–7018. 1993.PubMed/NCBI
5	Springer TA and Lasky LA: Cell adhesion. Sticky sugars for selectins. Nature. 349:196–197. 1991. View Article : Google Scholar : PubMed/NCBI
6	Imai Y, Singer MS, Fennie C, Lasky LA and Rosen SD: Identification of a carbohydrate-based endothelial ligand for a lymphocyte homing receptor. J Cell Biol. 113:1213–1221. 1991. View Article : Google Scholar : PubMed/NCBI
7	Kiguchi K, Takamatsu K, Tanaka J, Nozawa S, Iwamori M and Nagai Y: Glycosphingolipids of various human ovarian tumors: a significantly high expression of I³SO₃GalCer and Lewis antigen in mucinous cystadenocarcinoma. Cancer Res. 52:416–421. 1992.PubMed/NCBI
8	Iwamori M, Tanaka K, Kubushiro K, Lin B, Kiguchi K, Ishiwata I, Tsukazaki K and Nozawa S: Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha1,2-fucosyltransferase gene. Cancer Sci. 96:26–30. 2005. View Article : Google Scholar : PubMed/NCBI
9	Kiguchi K, Iwamori Y, Suzuki N, Kobayashi Y, Ishizuka B, Ishiwata I, Kita T, Kikuchi Y and Iwamori M: Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. Cancer Sci. 97:1321–1326. 2006. View Article : Google Scholar : PubMed/NCBI
10	Iwamori M, Iwamori Y, Kubushiro K, Ishiwata I and Kiguchi K: Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-derived cells with anticancer drug-resistance. J Biochem. 141:309–317. 2007. View Article : Google Scholar : PubMed/NCBI
11	Goupille C, Marionneau S, Bureau V, Hallouin F, Meichenin M, Rocher J and Le Pendu J: alpha1,2-Fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells. Glycobiology. 10:375–382. 2000. View Article : Google Scholar : PubMed/NCBI
12	Baldus SE, Hanisch FG, Pütz C, Flucke U, Mönig SP, Schneider PM, Thiele J, Hölscher AH and Dienes HP: Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence. Histol Histopathol. 17:191–198. 2002.
13	Iwamori M, Takamizawa K, Momoeda M, Iwamori Y and Taketani Y: Gangliosides in human, cow and goat milk, and their abilities as to neutralization of cholera toxin and botulinum type A neurotoxin. Glycoconj J. 25:675–683. 2008. View Article : Google Scholar : PubMed/NCBI
14	Lin B, Kubushiro K, Akiba Y, Cui Y, Tsukazaki K, Nozawa S and Iwamori M: Alteration of acidic lipids in human sera during the course of pregnancy: characteristic increase in the concentration of cholesterol sulfate. J Chromatogr B Biomed Sci Appl. 704:99–104. 1997. View Article : Google Scholar : PubMed/NCBI
15	Tanaka K, Kubushiro K, Iwamori Y, Okairi Y, Kiguchi K, Ishiwata I, Tsukazaki K, Nozawa S and Iwamori M: Estrogen sulfotransferase and sulfatase: roles in the regulation of estrogen activity in human uterine endometrial carcinomas. Cancer Sci. 94:871–876. 2003. View Article : Google Scholar : PubMed/NCBI
16	Ikehara Y, Shimizu N, Kono M, Nishihara S, Nakanishi H, Kitamura T, Narimatsu H, Tsuji S and Tatematsu M: A novel glycosyltransferase with a polyglutamine repeat; a new candidate for GD1alpha synthase (ST6GalNAc V)(1). FEBS Lett. 463:92–96. 1999.PubMed/NCBI
17	Yoshiki J, Kubushiro K, Tsukazaki K, Udagawa Y, Nozawa S and Iwamori M: High expression of uridine diphosphate-galactose: Lc₃Cer beta 1–3 galactosyltransferase in human uterine endometrial cancer-derived cells as measured by enzyme-linked immunosorbent assay and thin-layer chromatography-immunostaining. Jpn J Cancer Res. 88:669–677. 1997.PubMed/NCBI
18	Weston BW, Nair RP, Larsen RD and Lowe JB: Isolation of a novel human alpha (1,3)fucosyltransferase gene and molecular comparison to the human Lewis blood group alpha (1,3/1,4)fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities. J Biol Chem. 267:4152–4160. 1992.
19	Lo NW, Dennis JW and Lau JT: Overexpression of the alpha2,6-sialyltransferase, ST6Gal I, in a low metastatic variant of a murine lymphoblastoid cell line is associated with appearance of a unique ST6Gal I mRNA. Biochem Biophys Res Commun. 264:619–621. 1999. View Article : Google Scholar : PubMed/NCBI